You are here:Home-ADCs and PROTACs-PROTAC-NCOA4 PROTAC V3
NCOA4 PROTAC V3

Chemical Structure : NCOA4 PROTAC V3

CAS No.:

NCOA4 PROTAC V3 (NCOA4 degrader V3)

Catalog No.: PC-22832Not For Human Use, Lab Use Only.

NCOA4 PROTAC V3 is a highly efficient VHL-based nuclear receptor coactivator 4 (NCOA4) PROTAC degrader (DC50=3 nM, HeLa cells) and potent ferroptosis inhibitor.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

NCOA4 PROTAC V3 is a highly efficient VHL-based nuclear receptor coactivator 4 (NCOA4) PROTAC degrader (DC50=3 nM, HeLa cells) and potent ferroptosis inhibitor.
NCOA4 PROTAC V3 induces the degradation of NCOA4 via the UPS system in HeLa cells.
NCOA4 PROTAC V3 exhibits a concentration-and time-dependent capacity to attenuate the intracellular levels of NCOA4 in AML12 cells, with a calculated DC50 of 202 nM.
NCOA4 PROTAC V3 upregulates FTH1 and FTL levels in AML12 cells in a concentration-dependent manner, with no significant changes in the mRNA levels of FTH1 and FTL.
NCOA4 PROTAC V3 inhibits ferritinophagy and thus reduces the intracellular ferrous iron (Fe2+) level, induces elevation of ferritin.
NCOA4 PROTAC V3 inhibits the ferroptosis induced by CCl4 in AML12 cells, and in livers of CCl4-induced mice acute liver injury model. ameliorated liver damage in a CCl4-induced acute liver injury model.

Physicochemical Properties

M.Wt 1141.44
Formula C62H80N10O9S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N1-((R)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N5-(2-(2-(2-(2-((2-(3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)phenyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl)glutaramide

References

1. Ji J, et al. J Med Chem. 2024 Jul 24. doi: 10.1021/acs.jmedchem.4c00403.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: